Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen (Q39409873)

11 September 2017

Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen (English)

1 reference

eradication of infectious diseases

11 September 2017

0 references

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

10

1 reference

11 September 2017

L Bujanda

6

0 references

Víctor Moreno

object named as

V Moreno

3

0 references

author name string

J I Elizalde

1

1 reference

11 September 2017

J M Piqué

2

1 reference

11 September 2017

J D Morillas

4

1 reference

11 September 2017

I Elizalde

5

1 reference

11 September 2017

C M De Argila

7

1 reference

11 September 2017

A Cosme

8

1 reference

11 September 2017

A Castiella

9

1 reference

11 September 2017

Group of Study on Oesophageal and Gastric Diseases from The Spainish Gastroenterological Association

11

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Alimentary Pharmacology & Therapeutics

11 September 2017

1 reference

11 September 2017

16

1 reference

11 September 2017

3

1 reference

11 September 2017

577-586

1 reference

Atherosclerosis — An Inflammatory Disease

11 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Plaque disruption and thrombosis. Potential role of inflammation and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Relation of Helicobacter pylori infection and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Association of virulent Helicobacter pylori strains with ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Helicobacter pylori seropositivity in subjects with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Infection and inflammation-induced proatherogenic changes of lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Do triglycerides provide meaningful information about heart disease risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Urea breath tests in the management of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Reduced cholesterol is associated with recent minor illness: the CARDIA Study. Coronary Artery Risk Development in Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Role of cytokines in inducing hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

New perspectives on the management of low levels of high-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01202.X

10.1046/J.1365-2036.2002.01202.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference